Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
UBS
Johnson and Johnson
Mallinckrodt
Cerilliant
US Army
Teva
Cantor Fitzgerald
Merck

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,782,047

« Back to Dashboard

Summary for Patent: 4,782,047
Title: Aqueous steroid formulations for nasal administration
Abstract:A non-stinging aqueous anti-inflammatory steroid formulation suitable for intranasal administration comprises: an anti-inflammatory steroid in an amount between about 0.01% and about 0.05% (w/v); propylene glycol in an amount between about 2% and about 10% (w/v); PEG 400 in an amount between about 10% and about 25% (w/v); polysorbate 20 in an amount between about 1% and about 4% (w/v); an effective amount of a preservative; an effective amount of a stabilizer; an effective amount of an antioxidant; water; and pH buffering agent sufficient to adjust the pH of the resulting solution to between about 3.5 and about 7.
Inventor(s): Benjamin; Eric (Sunnyvale, CA), Anik; Shabbir (Mountain View, CA), Lin; Ya-Yun T. (Cupertino, CA)
Assignee: Syntex Pharmaceuticals International Ltd. (Hamilton, BM)
Application Number:06/866,171
Patent Claim Types:
see list of patent claims
Formulation; Use;

Drugs Protected by US Patent 4,782,047

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,782,047

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 65183 ➤ Try a Free Trial
Australia 609718 ➤ Try a Free Trial
Australia 7327387 ➤ Try a Free Trial
Canada 1288048 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
AstraZeneca
Deloitte
Harvard Business School
Chubb
Baxter
Farmers Insurance
Cipla
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.